Literature DB >> 23727383

Radicicol, a heat shock protein 90 inhibitor, inhibits differentiation and adipogenesis in 3T3-L1 preadipocytes.

Yonghan He1, Ying Li, Shuocheng Zhang, Ben Perry, Tiantian Zhao, Yanwen Wang, Changhao Sun.   

Abstract

Heat shock protein 90 (Hsp90) is involved in various cellular processes, such as cell proliferation, differentiation and apoptosis. As adipocyte differentiation plays a critical role in obesity development, the present study investigated the effect of an Hsp90 inhibitor radicicol on the differentiation of 3T3-L1 preadipocytes and potential mechanisms. The cells were treated with different concentrations of radicicol during the first 8days of cell differentiation. Adipogenesis, the expression of adipogenic transcriptional factors, differentiation makers and cell cycle were determined. It was found that radicicol dose-dependently decreased intracellular fat accumulation through down-regulating the expression of peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT element binding protein α (C/EBPα), fatty acid synthase (FAS) and fatty acid-binding protein 4 (FABP4). Flow cytometry analysis revealed that radicicol blocked cell cycle at G1-S phase. Radicicol redcued the phosphorylation of Akt while showing no effect on β-catenin expression. Radicicol decreased the phosphorylation of phosphoinositide-dependent kinase 1 (PDK1). The results suggest that radicicol inhibited 3T3-L1 preadipocyte differentiation through affecting the PDK1/Akt pathway and subsequent inhibition of mitotic clonal expansion and the expression/activity of adipogenic transcriptional factors and their downstream adipogenic proteins.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23727383     DOI: 10.1016/j.bbrc.2013.05.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Total control of fat cells from adipogenesis to apoptosis using a xanthene analog.

Authors:  Ching-Hsuan Tung; Myung Shin Han; Jianjun Qi
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

2.  Gut Microbiome Critically Impacts PCB-induced Changes in Metabolic Fingerprints and the Hepatic Transcriptome in Mice.

Authors:  Joe Jongpyo Lim; Xueshu Li; Hans-Joachim Lehmler; Dongfang Wang; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2020-09-01       Impact factor: 4.849

Review 3.  Caloric restriction mimetics: towards a molecular definition.

Authors:  Frank Madeo; Federico Pietrocola; Tobias Eisenberg; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2014-09-12       Impact factor: 84.694

4.  Ursolic acid increases glucose uptake through the PI3K signaling pathway in adipocytes.

Authors:  Yonghan He; Wen Li; Ying Li; Shuocheng Zhang; Yanwen Wang; Changhao Sun
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

Review 5.  Targeting Cell Survival Proteins for Cancer Cell Death.

Authors:  Manoj K Pandey; Sahdeo Prasad; Amit Kumar Tyagi; Lokesh Deb; Jiamin Huang; Deepkamal N Karelia; Shantu G Amin; Bharat B Aggarwal
Journal:  Pharmaceuticals (Basel)       Date:  2016-02-25

6.  Expression of fatty acid-binding protein-4 in gastrointestinal stromal tumors and its significance for prognosis.

Authors:  Wei-Jie Zang; Zi-Niu Wang; Yi-Lin Hu; Hua Huang; Peng Ma
Journal:  J Clin Lab Anal       Date:  2021-09-24       Impact factor: 2.352

7.  Ursolic acid inhibits adipogenesis in 3T3-L1 adipocytes through LKB1/AMPK pathway.

Authors:  Yonghan He; Ying Li; Tiantian Zhao; Yanwen Wang; Changhao Sun
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

8.  Hsp90 blockers inhibit adipocyte differentiation and fat mass accumulation.

Authors:  Sébastien Desarzens; Wan-Hui Liao; Caterina Mammi; Massimiliano Caprio; Nourdine Faresse
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

Review 9.  Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy.

Authors:  Erwan Eriau; Juliette Paillet; Guido Kroemer; Jonathan G Pol
Journal:  Cancers (Basel)       Date:  2021-03-12       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.